Chief Clinical Officer
Aperiomics
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Dr. C. Alexander Valencia, Ph.D. is a skilled molecular geneticist and an expert in translating next-generation sequencing technology into clinical practice through the development and implementation of clinical assays, interpretation of genomic data, and by associating novel genes to human diseases. As Aperiomics’ Chief Clinical Officer, he oversees clinical test development, validations, regulatory affairs, and operations on behalf of the company.
With over a decade of administrative experience in major laboratories across the United States, Dr. Valencia has managed teams of technologists, project managers, genetic counselors, marketing specialists, and bioinformaticians. Prior to joining Aperiomics, he served as the molecular laboratory director at Cincinnati Children’s Hospital Medical Center and PerkinElmer Genomics. Setting the standard for genetics in medical practice, Dr. Valencia has made significant contributions in the field of clinical genomics, publishing more than 50 peer-reviewed articles and speaking at numerous conferences.
Dr. Valencia received his Ph.D. from Carleton University and the University of Ottawa and completed his post-doctoral studies in biochemistry/molecular biology and clinical molecular genetics at the University of North Carolina Chapel Hill and Emory University, respectively.
